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Abstract
Background: Discovery that the transcriptional output of the human genome is far more complex than predicted
by the current set of protein-coding annotations and that most RNAs produced do not appear to encode proteins
has transformed our understanding of genome complexity and suggests new paradigms of genome regulation.
However, the fraction of all cellular RNA whose function we do not understand and the fraction of the genome
that is utilized to produce that RNA remain controversial. This is not simply a bookkeeping issue because the
degree to which this un-annotated transcription is present has important implications with respect to its biologic
function and to the general architecture of genome regulation. For example, efforts to elucidate how non-coding
RNAs (ncRNAs) regulate genome function will be compromised if that class of RNAs is dismissed as simply
‘transcriptional noise’.
Results: We show that the relative mass of RNA whose function and/or structure we do not understand (the so
called ‘dark matter’ RNAs), as a proportion of all non-ribosomal, non-mitochondrial human RNA (mt-RNA), can be
greater than that of protein-encoding transcripts. This observation is obscured in studies that focus only on polyA-
selected RNA, a method that enriches for protein coding RNAs and at the same time discards the vast majority of
RNA prior to analysis. We further show the presence of a large number of very long, abundantly-transcribed
regions (100’s of kb) in intergenic space and further show that expression of these regions is associated with
neoplastic transformation. These overlap some regions found previously in normal human embryonic tissues and
raises an interesting hypothesis as to the function of these ncRNAs in both early development and neoplastic
transformation.
Conclusions: We conclude that ‘dark matter’ RNA can constitute the majority of non-ribosomal, non-
mitochondrial-RNA and a significant fraction arises from numerous very long, intergenic transcribed regions that
could be involved in neoplastic transformation.
Background
A variety of techniques, most notably tiling arrays [1-4],
massive sequencing of complimentary DNAs (cDNAs)
[5,6] and cDNA tags [7], has consistently identified the
presence of RNA molecules encoded from regions of
the genome not currently annotated as exons of pro-
tein-coding RNAs in human cells [8]. Collectively, these
RNA molecules were dubbed ‘dark matter in the gen-
ome’ [9]. While these approaches underscored the com-
plexity of transcriptional output from the human
genome [10], tiling arrays could predict only the com-
plexity, but not the relative mass of ‘dark matter’ RNA
as a fraction of total transcription and, hence, they
could not make strong concl u s i o n sa b o u ti t si m p o r -
tance. Similarly, the majority of methods for cDNA
sequencing have either used polyA+ selected RNA and/
or amplification for library construction, both of which
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cannot accurately reflect the profile of all cellular RNAs.
These technological limitations in assessing all cellular
RNAs have led to the notion that non-coding RNAs
(nc-RNA) represent only a minor proportion of the total
mass of RNA molecules relative to protein-coding spe-
cies and may arise only as a by-product of transcrip-
tional noise [9,11]. If so, they would not be worthy of
additional analysis while others have suggested that the
situation merits further study [12].
The advent of next-generation sequencing technolo-
gies and their application to RNA analysis [13] provides
the opportunity for us to re-assess the relative mass of
t h en c - R N A sa n d ,t h u s ,d i r e c t l yp o s et h eq u e s t i o no f
how prevalent and important this class of RNAs might
be. However, care must be taken to ensure the RNA
analysed is representative of the entire cell and that the
limitations of the technologies being used are under-
stood to minimize the impact of any biases. One initial
report [14] has suggested that nc-RNAs represent only a
minor fraction of RNA in a mammalian cell and that
most of these non-coding species consisted of intronic
by-products generated from unspliced RNAs. In order
to further address this question, we have used single-
molecule sequencing (SMS) to reduce the potential for
representational biases by avoiding amplification and
minimizing sample preparation [15,16]. We show that
when total RNA is sequenced rather than just the highly
selected polyadenylated RNAs, ‘dark matter’ RNAs
represent a significant fraction, sometimes even the
majority, of the stable non-ribosomal, non-mitochon-
drial RNAs (mtRNA) in a cell. Furthermore, gene-desert
regions, currently devoid of annotations, are found to be
expressed at abundant levels and RNA species from
these regions may be over-represented during or follow-
ing neoplastic transformation.
We provide estimates of the relative mass of the ‘dark
matter’ RNA in cells of two organisms - human and fly.
To our knowledge, while used in a number of reports,
this term has not been defined and, thus, we offer our
definition of this term: ‘dark matter’ RNA includes any
RNA whose function we do not currently understand
and any RNA that is currently un-annotated. The latter
category may include both protein-coding and nc-RNAs.
A more detailed breakdown of what is included and
how these species might arise is provided in the Addi-
tional File 1: Definition of dark matter.
Another parameter requiring definition is the mea-
surement for transcriptome complexity used here. In
general, the fraction of ‘dark matter’ RNA could be mea-
sured either as a fraction of nucleotide bases in the gen-
ome that are used to encode these transcripts or as the
relative mass of these RNAs as a fraction of mass of all
RNAs in the cell after removing ribosomal and mtRNAs.
Most techniques, notably tiling arrays have provided the
former estimate. Importantly, however, this estimator
a l o n ec a n n o tp r o v i d eac o m p l e t ed e s c r i p t i o no ft h e
complexity of ‘dark matter’ R N Aa si ti sp o s s i b l et h a ti t
can be highly complex in terms of the sequences present
in this population and yet comprise a minute fraction of
total RNA population by mass. This has been suggested to
be the case by the recent report of van Bakel et al. who
estimate that ‘dark matter’ RNA constitutes 12% of all
RNA by mass [14]. In that report, the authors have lever-
aged the ability of a next-generation sequencing to count
individual sequencing reads and assign them to either
known or ‘dark matter’ RNA categories. The fraction of
total reads in each category of RNA represents its relative
mass. We have also used the relative mass as defined by
fraction of reads falling within a certain category as an
estimator of the abundance of RNA. We used the number
of reads as opposed to the total number of nucleotides
covered by the reads to estimate the relative mass of RNA
since the SMS reads do not have the same lengths.
Results and discussion
In order to evaluate the true nature of the complete cel-
lular RNA population, we analysed RNA from various
tissue sources and different RNA preparations in two
different species: human and Drosophila (Figure 1 and
Additional File 2: Table S1). The filtered sequence reads
used in this work have been deposited in the National
Center for Biotechnology Information Short Read
Archive [SRA:SRP004776]. PolyA+ RNA, total RNA and
total RNA depleted of ribosomal RNA were studied. As
described in the Materials and Methods section, RNA
preparations were treated with saturating concentrations
of DNAse I followed by purification over columns to
eliminate small amounts of any remaining partially-
digested small DNA pieces. This step can also remove a
substantial fraction of RNAs below 200 bases and, thus,
this work is primarily aimed at RNAs longer than 200
bases. The priming of RNA with random hexamers and
reverse transcription generated first-strand cDNA which
was then tailed with terminal transferase and deoxyade-
nosine triphosphate (dATP). This was followed by
sequencing using single-molecule sequencing after
hybridization to a flow cell surface with covalently
bound poly dT50 [17]. No amplification, ligation or size
selection were used in cDNA preparation, minimizing
methodological biases [18]. Each cDNA sample was
sequenced on one or more channels of a HeliScope
Genetic Analysis System with the resulting filtered reads
(25-55 bases, average read length 33-36 bases depending
on the run) aligned to the complete human or Droso-
phila genomes supplemented with the sequence of the
complete ribosomal DNA (rDNA) repeat (Materials and
Methods section). Reverse transcription is known to
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Page 2 of 15produce spurious second-strand cDNA [19], so reads
from both strands of the genome were combined in
order to avoid sense/antisense artifacts. The unique
mapping reads from human tissue sources were further
filtered to exclude sequences aligned to rDNA
sequences, the mitochondrial genome, as well as to
genomic repeats annotated by the RepeatMasker pro-
gram as rRNA. After filtering, the remaining informative
reads were used for subsequent analyses, including a
comparison to the known annotations defined by the
University of California, Santa Cruz (UCSC) Genes or
the FlyBase Genes tracks from the UCSC browser.
As shown in Figure 1 and Additional File 2: Table S1,
the highest fraction of non-exonic reads consistently
occurred in total RNA (approximately 51%-64%) and
total RNA depleted of ribosomal RNA (RiboMinus
RNA, approximately 50%-62%). Strikingly lower propor-
tions of non-exonic reads (or ncRNAs) occurred in the
polyA+ fraction, although they still accounted for
approximately 19%-33% of the informative reads. Two
different polyA+ RNA preparation methods for human
liver RNA, using either magnetic beads or oligo-dT cel-
lulose purification, produced similar yields of informa-
tive reads (81% and 84.4%, respectively) that overlap
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Figure 1 Distribution of single-molecule sequencing (SMS) reads among exonic, intronic and intergenic regions in polyA+, RiboMinus
and total RNA. RNA samples were prepared as described in the Materals and Methods section of the paper for sequencing. Each source of
RNA [K562 cells, human liver or brain tissue and adult flies (Drosophila)] was used either directly (total RNA) or after fractionation by RiboMinus
treatment or selection for the polyA containing RNAs. Each sample was sequenced on one or more channels. Reads were aligned to hg18 or
dm3 version of the human or fly genomes. After the removal of reads that aligned to the mitochondrial and ribosomal sequences, the
remaining sequences were assigned as exonic (white), intronic (grey) or intergenic (black) based on the University of California Santa Cruz genes
database and the percentages found for each are shown as pie charts. The exact read data can be found in Additional File 2: Table S1.
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f r a c t i o no fn o n - e x o n i cR N A s ,w i t ht h en o r m a lb r a i n
having the highest proportion of ncRNA transcripts, fol-
lowed by the leukaemia cell line K562 and then the
liver, which showed the lowest level. Since these data
were not biased by potential effects of amplification or
ligation, they are more likely to accurately represent the
relative mass of differentp o p u l a t i o n so fR N A st h a n
other techniques which require additional processing
steps. Any skewing in favour of non-exonic RNAs that
could be induced by the process of RNA purification
from the cell or reverse transcription would have also
occurred to a similar extent in other studies. Overall,
this suggests that the un-annotated transcriptome, as
defined by the reads mapping outside exons of protein-
coding RNAs, represents the majority of RNAs by mass,
comprising up to two-thirds of all non-ribosomal, non-
mtRNA in a human cell. However, of interest and con-
sistent with the previous observation based on tiling
arrays [20], RNA from adult Drosophila flies did not
have as much non-exonic RNAs by mass as human
cells, comprising approximately 11% of the polyA+ RNA
and 19% of the RiboMinus RNA. This is consistent with
earlier observations based on tiling arrays suggesting
that Drosophila does not have as much ‘dark matter’
RNA as human cells [20] and supports the previous sug-
gestion that the fraction of the ‘dark matter’ RNA
increases with increasing organismal complexity [21]. As
with the human samples, the fly samples have a higher
fraction of ‘dark matter’ RNA in total rather than polyA
+ RNA (Figure 1 and Additional File 2: Table S1). The
data and analysis below refer to human samples unless
otherwise specified.
In order to further investigate the complexity of tran-
scriptional output in human samples, we have analysed
six different Ewing Family of Tumours (EFT) samples
from four different patients. These included a pair of
matching cell lines derived from a single patient, one
from the primary-tumour established in culture prior to
chemotherapy (CHLA-9) and one from a metastatic-
lesion cultured after chemotherapy (CHLA-10). A sec-
ond matched set of samples was derived from primary
and metastatic EFT tumours from a different patient.
An additional primary and metastatic tumour sample
were each obtained from different patients (see Materi-
als and Methods section). The primary and metastatic
tumour samples served to exclude the possibility that
the observed non-exonic RNAs are an artifact of tumour
cell line culture conditions. Figure 2 and Additional File
3: Table S2 summarizes the analysis of these samples
profiled using RiboMinus RNA. Consistent with the pre-
vious results, non-exonic RNAs represented 43%-63% of
all non-ribosomal, non-mtRNAs by mass. Primary
tumour samples had more non-exonic RNAs (50%-63%)
than the cell lines (43%-45%), which could be due to the
more heterogeneous nature of the tumour tissues.
Tumours are known to be comprised of multiple cell
types with normal tissue stroma yielding up to 50% of
the total RNA mass and different cell-types could have
different non-exonic RNAs expression profiles [2].
Thus, overall, 30%-52% of all informative reads in the
human RiboMinus RNA did not overlap exons and fell
within intronic regions (Additional File 2: Table S1,
Additional File 3: Table S2, Figures 1 and 2) with an
average of 40%, representing a significantly higher frac-
tion than the 5.8% reported by van Bakel et al. [14].
Intronic reads could simply represent unspliced RNAs
and to some extent this will be the case. However, the
abundance and specificity that we find among intronic
RNAs indicate they are not simply bystanders but sug-
gest a more complex role. Introns have been shown in
several instances to harbour known non-coding func-
tional RNAs, such as the KCNQ1OT1 transcript
involved in imprinting [22]. By RNA mass in a human
cell, transcripts emanating from intronic sequences
approximately equal that of exonic sequences but this
large amount of intronic sequence cannot be explained
just by the fact that introns are longer and, thus, accu-
mulate more reads. The density of reads from individual
introns can be quite abundant and similar to, or higher
t h a n ,t h a to fe x o n i cr e g i o n s .T h i si se x e m p l i f i e db yt h e
known ncRNA KCNQ1OT1 embedded within the pro-
tein-coding KCNQ1 locus and transcribed from the
opposite strand, indicating it is not simply a splicing
artifact (Figure 3). Additional examples in loci not cur-
rently known to harbour ncRNAs are shown on Figure
4b. In contrast, RNA transcripts from some introns are
v i r t u a l l ya b s e n t( s e eF i g u r e4 a ) .I nt h eIMMP2L and
SLCO1B3/LST-3TM12 loci (Figure 4b), the density of
reads in intronic regions is equal to, or higher than, in
t h ee x o n i cr e g i o n s ,w i t han o t a b l ee n r i c h m e n to fi n t r o -
nic sequences in the RiboMinus compared to polyA+
RNA. Overall, such examples are not rare. If we con-
sider all spliced UCSC Genes annotations expressed in
K562 defined by the presence of at least 50 reads per 10
M in intronic and exonic regions, we identify 34,962
transcripts. Of these, 3760 have at least one intron
w h o s ea v e r a g er e a dd e n s i t yi se q u a lt o ,o rh i g h e rt h a n ,
the density of the exons. It is also important to empha-
size that we obtained these results from an analysis of
cellular total RNA, not nuclear-enriched RNAs and,
thus, the relative mass of introns in the total RNA pool
is impressive.
Overall, our results are consistent with the fact that
introns produce abundant stand-alone transcripts. Con-
sistent with this, Louro et al. [23] have found that over
80% of human RefSeq loci have 78,147 transcriptional
units formed by clusters of expressed sequence tags
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Page 4 of 15(ESTs) that map totally within introns, suggesting that
introns contain transcripts that are not part of pre-mes-
senger RNA. Importantly, these units are not randomly
distributed in the genome [24]. Furthermore, intronic
RNAs were previously found to represent a compilation of
different RNA species in addition to independent sense
and antisense transcripts - transcripts retaining specific
i n t r o n sa sw e l la sR N Am o l e c u l e sw i t ha l t e r n a t i v ee x o n s
and alternative un-translated regions [4].
Although less frequent than intronic reads, a substan-
tial number of RiboMinus RNA reads also mapped to
intergenic space. Intergenic reads comprise 24%-37% of
all non-exonic reads and approximately 15%-18% of
all informative reads in the RiboMinus RNA samples
(Figure 1 and Additional File 2: Table S1). Interestingly,
we also noticed a number of very long, abundant inter-
genic transcribed regions spanning hundreds of kbs of
genome virtually devoid of annotations, as illustrated in
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Figure 2 Distribution of single-molecule sequencing (SMS) reads among exonic, intronic and intergenic regions in RiboMinus RNA of
different Ewing Family of Tumours samples. RNA samples were prepared as described in the Materials and Methods section of the paper for
sequencing. Each source of RNA (from immortalized cell lines (CHLA), from primary and metastatic tumours, from primary and metastatic
tumours from one individual (matched) and from primary and metastatic tumours from different individuals (unmatched), was used after the
removal of most of the ribosomal RNA by RiboMinus treatment. Each sample was sequenced on one or more channels. Reads were aligned to
the hg18 or dm3 version of the human or fly genomes. After removal of reads that aligned to mitochondrial and ribosomal sequences, the
remaining sequences were assigned as exonic (white), intronic (grey) or intergenic (black) based on the University of California Santa Cruz genes
database and the percentages found for each are shown as pie charts. The exact read data can be found in Additional File 3: Table S2.
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Page 5 of 15Figures 4c and 4d. Similar to the intronic RNAs, these
transcripts were also enriched in the RiboMinus RNAs,
although still detectable in polyA+ RNA samples.
These very long intergenic RNAs were found at signifi-
cantly greater abundance in cell lines derived from malig-
nancies, such as K562, compared to RNA from the
normal liver and brain (Figure 4c and 4d). In order to
further investigate this in cancer, we analysed the six EFT
samples and found many very long intergenic transcribed
regions specific to these EFT samples, one example of
which appears in Figure 5a. A region of approximately
650 kb on chromosome 7 was observed in total RNA
from the EFT samples, but not in RNAs from K562, nor-
mal liver or the brain. Interestingly, transcription from
this region occurs in at least three of the six EFT samples,
including a cell line and two solid tumour samples, sug-
g e s t i n gt h a ti ti sn o ta na r t i f a c to fin vitro cell culture.
Furthermore, we detected long, intergenic transcribed
regions specific to K562 cells that were transcribed from
an approximately 300 kb intergenic region on chromo-
some 21 and not found in EFT samples (Figure 5b).
While any given genomic region could be rearranged,
amplified or deleted in the cancerous cells, it is unlikely
that the same regions are rearranged in samples derived
Figure 3 Detection of a known intronic non-coding RNA (ncRNA) KCNQOT1 in RiboMinus RNAs from Ewing Family of Tumours (EFT)
and K562 tumour samples. Gene expression arising from chromosome 11, positions 2,400,000 to 2,800,000 (near the KCNQ1 gene) is shown
for seven different RNA samples, six EFT samples and the K562 cell line. For each sample, the Y axis (0-10) shows the density of reads per
genomic base overlapped by at least one read in 10 million non-ribosomal, non-mitochondrial reads with the X-axis showing the chromosomal
position. The location of annotated exons on the sense strand (+) for KCNQ1 is shown between the chromosomal position and the expression
levels for each sample. The position of the antisense (-) intronic ncRNA KCNQ1OT1 is shown below the chromosomal position. All gene
annotations and genomic coordinates are based on University of California Santa Cruz genes and hg18 version of the genome.
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derived from four different patients.
In order to identify all such expressed intergenic
regions, we pooled non-genic reads from the EFT sam-
ples and K562 cells and defined intergenic RNA domains
of at least 50 kb in length (Materials and Methods sec-
tion). Overall, 580 such domains were found (Additional
File 4: Table S3). We thus propose to classify these inter-
genic regions as very long intergenic non-coding (vlinc)
regions. As described below, expression from vlinc
regions can be substantial and significantly higher in can-
cerous tissues than in normal tissues.
The total stable RNA output of a vlinc region can be
quite substantial based on relative mass. In the case of
K562, if both the vlinc and known protein-coding tran-
s c r i p t sa r er a n k e db yr e l a t i v em a s s ,t h et o pe x p r e s s e d
vlinc (coordinates chr7:119013253-119337443, Addi-
tional File 4: Table S3) has a higher relative mass than
the ninth most expressed known transcript which cor-
responds to the eukaryotic translation elongation fac-
tor 2, EEF2 (Additional File 5: Table S4). Of further
interest is the observation that seven of the top eight
expressed annotated transcripts in this cell line corre-
s p o n dt oa n n o t a t e dn c - R N A s ,s u c ha sMALAT1 and
RMRP (Additional File 5: Table S4). Thus, the only
protein-coding RNA that is higher in relative mass
than the top vlinc RNAs is an isoform of epsilon glo-
bin gene (HBE).
Figure 4 The presence of abundant non-exonic RNAs in introns and intergenic regions in human cells. Chromosomal locations and gene
regions that display different patterns of intronic or intergenic expression are shown in panels A-D. For each region, the chromosome, annotated
gene and strand are shown at the bottom with annotated exons represented by boxes. Above the exons, chromosomal positions based on the
University of California Santa Cruz genes and the hg18 version of the genome are shown. The source of the sample RNA (K562, liver or brain)
and the type of RNA preparation (RiboMinus or polyA selected) are shown next to the Y-axis. Examples of loci producing little or large amounts
of intronic RNAs are shown in panels A and B. Examples of very long intergenic transcribed regions are shown in panels C and D. The Y axis
show the density of reads per each genomic base overlapped by at least one read in reads per 10 million of non-ribosomal, non-mitochondrial
reads.
Kapranov et al. BMC Biology 2010, 8:149
http://www.biomedcentral.com/1741-7007/8/149
Page 7 of 15Table 1 illustrates the tissue specificity of the K562
vlincs by comparing the ranks of the top 15 vlincs (ranked
based on their relative mass) in this cell line to their ranks
in other tissues both tumour and normal. As one can see,
the ranks of the top 15 vlincs are significantly higher in
other tissues. Also, Table 1 shows the ranks of the top 15
vlincs if they were ranked with the 65,260 UCSC Genes:
the ranks would range from 9-100 among the ~65 K anno-
tated genes again underscoring the fact that these regions
are quite abundant.
The total stable RNA output of vlinc regions tends to
be higher in cancerous tissues than in normal ones. The
maximum number of normalized counts for the seven
tumour (6 EFT tumours and K562) and two normal
samples (liver and brain) was calculated for each vlinc
(Additional File 4: Table S3). The tumour/normal fold
ratio of the maximal counts was then calculated for each
vlinc (Additional File 4: Table S3). The median ratio was
approximately 4.8, showing that most of the vlincs are
more abundant in the tumour samples (T-test, P=5 . 5×
10
-27). Furthermore, of the 580 vlinc regions, 427 had a
ratio that was double or more and, for 222 vlincs, this
ratio was 10 times higher. In contrast, there were three
and zero vlinc regions whose maximal read count in a
normal tissue was two and 10 times higher, respectively,
than that in a tumour tissue/cell line.
Additionally, the total stable RNA output of vlinc
regions can differentiate between different tumours and
Figure 5 An example of very long transcribed intergenic regions identified in tumour cells. An example of a locus with high expression
between annotated genes on chromosome 7 that was found in several Ewing Family of Tumours (EFT) cell lines and tissues but not in K562 or
normal tissues is shown in panel A with chromosomal position along the X axis. A locus on chromosome 21 that was found to have high
expression in K562 but not EFT samples or normal tissues is shown in panel B. The EFT primary No,1 and metastatic No.1 samples correspond to
the CHLA-9 and CHLA-10 cell lines (see the Materials and Methods Section of the paper) and the remainder are from patient EFT samples, K562
cells, or normal tissues (liver and brain). The K4-K36 domains which harbour large intergenic non-coding RNAs, as reported by Khalil et al. [27],
are also shown. The Y axis show the density of reads per each genomic base in 10 million non-ribosomal, non-mitochondrial reads. The
chromosome (chr) of origin and strand of a transcript (+) or (-) are indicated.
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patients. A non-parametric Spearman correlation analysis
among all of the pair-wise combinations of the EFT (six
cell lines/tissues, two pairs from the same patient and
one pair from a different patient), normal brain and liver
sample and the K562 leukaemia cell line was performed
based on the expression values for vlinc and UCSC
Genes (Additional File 4: Table S3 and Additional File 5:
Table S4). The following average correlation metrics
based on all relevant pair-wise correlations were then cal-
culated: between the EFT samples from the same patient;
between the EFT samples from different patients;
between the EFT and the normal tissues; and between
the EFT samples and the leukaemia cell line. The correla-
tion matrix is shown in Additional File 6: Table S5. For
the UCSC Genes, sum of expression within each anno-
tated transcript of the UCSC Genes database was calcu-
lated across all samples (Additional File 3: Table S2). The
transcripts were then sorted by the sum expression level
and the top two quartiles (Q1-Q2) were used to calculate
the correlations. This was done to avoid inflation of the
correlations due to transcripts not expressed in any of
the tissues. The average correlation between the EFT
samples from the same patient was, as expected, quite
high using either the expression of UCSC Genes or vlincs
(0.89 and 0.87, respectfully). It is worth noting that the
pair of EFT samples from the same patient were repre-
sented by the primary and metastatic tumour isolated at
significantly different time periods (months) from each
other and, in the case of the one pair represented by the
CHLA-9/-10 cell lines, cultured independently. This sug-
gests that the expression of vlinc regions can be main-
tained for significant periods of time and suggests an
important biological role. The average correlation
between the EFT samples from the different patients was
still high using expression of UCSC genes but lower
using vlincs: 0.72 and 0.53, respectively. The latter was
similar to those calculated between EFT samples and
normal tissues: 0.36 and 0.49 based on UCSC genes and
vlinc regions, respectively. Interestingly, expression levels
of vlincs in EFT tumours were extremely different from
the leukaemia K562 cell line (average correlation of 0.02).
However, the average correlation between the two
tumour types using known genes was still relatively high:
0.51. Although the number of tumour tissues used in this
study is low, these observations suggest that the ‘dark
matter’ RNAs produced from the vlinc regions can differ-
entiate between different tumours, perhaps even better
than the annotated genes. The ability to differentiate
molecularly defined subgroups in the case of the EFT
and, probably other tumours, is especially interesting
since tumours are known to be heterogeneous and, in the
case of EFT, are often referred to as a ‘family of tumours’.
Further, the diagnosis of EFT is often challenging due to
its non-variant, microscopic appearance [25,26]. This
data further confirms the notion of heterogeneity and
suggests that the ‘dark matter’ RNAs could, in fact, be as
good as or even better a discriminator than other meth-
ods, including coding RNAs, which are not unique to any
given tumour, for identifying molecular subgroups within
Table 1 Ranking of the top 15 very long intergenic non-coding (vlincs) in the K562 cell line in other tissues [Ewing
Family of Tumours (EFT) and normal) and among University of California Santa Cruz (UCSC) genes
ID Chromosome start Stop Relative
mass
(%)
K562
rank
Average
rank EFT
tumours
Minimum
rank EFT
tumours
Average rank
liver and
brain
Minimum
rank liver and
brain
Rank
among
UCSC
genes
Vlinc_470 chr7 119013253 119337443 0.172 1 412 199 367 278 9
Vlinc_352 chr4 127557220 128001463 0.160 2 344 265 201 148 11
Vlinc_479 chr7 145112991 145362753 0.158 3 18 6 1 1 12
Vlinc_518 chr8 130323251 130656488 0.157 4 342 229 238 104 13
Vlinc_500 chr8 91302893 91655164 0.131 5 382 353 205 189 18
Vlinc_568 chrX 120153582 120594672 0.078 6 281 241 129 63 40
Vlinc_94 chr12 90597529 90798365 0.070 7 492 461 375 331 48
Vlinc_453 chr7 10409634 10632037 0.064 8 325 200 275 194 62
Vlinc_454 chr7 10638258 10786122 0.060 9 488 463 466 460 74
Vlinc_203 chr18 73753244 73834670 0.055 10 566 547 558 543 80
Vlinc_180 chr16 83939419 84202366 0.052 11 93 55 18 8 86
Vlinc_157 chr16 7897639 8105614 0.052 12 476 432 323 244 87
Vlinc_77 chr12 23219253 23449659 0.050 13 504 448 354 298 93
Vlinc_377 chr5 53642299 53764051 0.048 14 477 363 449 440 97
Vlinc_93 chr12 90280166 90554683 0.048 15 454 410 205 94 100
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tumour types.
Previously, human large intergenic non-coding (link)
RNAs were identified in normal human embryonic and
stem cell lines [27] and we sought to determine whether
the link regions were overlapping. In fact, the majority
of the link transcribed regions we have identified did
not overlap the known human lacuna regions and, thus,
represent novel RNAs that are also large, interagency
and non-coding, as exemplified in the four examples
shown (Figure 4c and 4d, Figure 5a and 5b). These latter
regions have known lacuna regions located nearby, with-
out overlap, while the former do not have lacuna
regions in their vicinity. Furthermore, the interagency
regions identified here achieve much greater lengths
than known lacunas, with a median size of ~84 kb ver-
sus 21 kb for the lacunas (significant at P =1 . 7 2×1 0
-
53, t-test). Overall, 37% (215/580) of the regions over-
lapped the K4-K36 domains harbouring lacunas as
reported by Khalid et al. [27]. However, even when
overlapping, the lacuna regions corresponded to only a
fraction of our interagency regions: the percent of base
pairs in the interagency regions found here only over-
lapped the lacuna regions by approximately 19% (13.51/
68.51 Map). However, the overlap between the two cate-
gories of the interagency transcribed regions is highly
significant (P-value < 10
-16, chi-square test). This is
interesting because the two regions were detected using
different experimental approaches and even more so,
they were found in very different types of tissues. Links
were originally found in normal embryonic tissues/cell
lines, while links were originally found in tumour tis-
sues. This suggests a tantalizing possibility that links are
also expressed very early in development, perhaps at
very specific stages of development, which explains why
they so far have eluded detection and the determination
of function during early development.
We also analysed whether vlincs could be conserved
across species, at least in terms of the syntenic location.
In order to do this we took advantage of the data denot-
ing 5’ and 3’ ends of mouse transcripts (the reliable
cluster dataset) from the FANTOM3 consortium [5].
We took the coordinates of 181,047 such clusters and
converted these clusters into regions of the hg18 version
of the human genome (Materials and Methods section).
Overall, 165,169 clusters could be remapped to hg18. Of
the 165,169 clusters, 7456 were intergenic and, of those,
172 spanned at least 50 kb of genomic space - the mini-
mal size of a vlinc region. These 172 clusters are thus
analogous to our vlinc regions based on size and loca-
tion in the intergenic regions. Overall, 15 vlinc regions
were found to overlap 21 (out of 172) FANTOM3 clus-
ters by at least 10 kb (Additional File 7: Table S6).
Sometimes a vlinc region overlapped more than one
cluster (Additional File 7: Table S6). Overall, given the
small span of the genomic space covered by the vlincs
and the 172 FANTOM3 clusters, the overlap was signifi-
cant (P-value < 10
-16, chi-square test). Furthermore, in
the cases of 13 vlincs, the region of overlap was more
the 50% of the length of either the vlinc or the FAN-
TOM3 cluster it overlapped (Additional File 7: Table
S6).
Thus, some vlincs are conserved in mouse at least in
the syntenic locations. The fact that only 15 (or 13 if
more stringent criteria above are used) vlincs are con-
served in mouse is probably due to the fact that: (1)
only 172 such regions were identified in FANTOM3,
probably due to usage of polyA+ RNA for library con-
structions by the FANTOM3 consortium, significantly
lowering potential for overlap; and (2) differences in bio-
logical material - vlincs appear to be highly tissue
specific.
It is difficult to currently estimate the complexity and
properties of RNA molecules harboured within the vlinc
regions. What is currently annotated explains a minute
fraction of the complexity found in these regions, both
in terms of the base pair coverage and fraction of reads,
even if we include additional databases, such as RefSeq,
Ensemble and all spliced ESTs. For example, exons of
the spliced ESTs cover only ~0.6% of the genomic
sequences covered by all vlincs: 434,530 out 68,509,810
bp correspondingly. Also, taking K562 as an example,
approximately 2% of all reads (7,745/358,600) that fall
within the vlinc regions can be accounted for by the
exons of the spliced ESTs. This number climbs to 3.5%
if exons of all spliced ESTs, UCSC Genes, RefSeq and
Ensemble are combined (12,392/358,600 reads). As
mentioned above, however, when summarized over each
vlinc region, these transcripts are quite abundant based
on how many reads one needs to minimally cover all
non-ribosomal, non-mt RNAsi nah u m a nc e l l .N e v e r -
theless, elucidation of the structures of transcripts
within the vlinc regions is of paramount importance.
However, this can only be done by targeting each region
and cloning and sequencing each full-length cDNA, to
the extent that this is even possible. Both cloning and 5’
and 3’ RACE (Rapid Amplification of cDNA ends)
experiments may prove impossible if the individual tran-
scripts turn out to be very long, necessitating new stra-
tegies for characterizing these regions.
Given that we sequenced total as well as polyA-
selected RNA, we can also estimate the relative mass of
non-ribosomal, non-mt RNAs in both fractions and also
estimate the number of reads required to fully sequence
this fraction from one cell. Sequencing of total RNA not
depleted of ribosomal RNA yields a value of about 6%
(range 4%-8%) of non-ribosomal and non-mt RNA as a
fraction of total RNA in cell by mass. Based on the
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pg) and an average read of 35 bases (representing 2 ×
10
-20 g RNA), we would need greater than 100 million
reads to sequence all non-ribosomal, non-mt RNA in a
single human cell. Since the number of reads in this
study of RiboMinus RNAs represents only a fraction of
the total number of reads estimated above, we can safely
assume that we sequenced less than one cellular equiva-
lent of RNA. Thus, the readily apparent detection of the
above non-exonic RNAs, as s h o w ni nF i g u r e s3 - 5 ,s u g -
gests that their expression occurs at significant levels
compared to protein encoding RNAs and certainly
much higher than one copy per cell. We can also esti-
mate that the polyA-selected material probably repre-
sents only a small fraction (approximately 5%-25%) of
non-ribosomal, non-mtRNA. This estimate follows from
the typical yield of a single polyA selection, which repre-
sents approximately 1%-2% of starting total RNA
amounts, of which approximately 50% is still ribosomal
or mtRNA and, from the observation made in this
study, that total RNA contains on the order of 6%
(range 4%-8%) non-ribosomal and non-mt RNA.
Conclusions
In summary, we show that the relative mass of ‘dark-
matter’ RNAs is both substantial and, in some cases,
greater than that of protein encoding transcripts. We
find that the ‘dark-matter’ RNA fraction typically repre-
sents 50%-65% of all non-ribosomal, non-mt RNA by
mass in many normal and neoplastic tissues. We derived
these estimates using single-molecule sequencing of
cDNAs that avoids amplification, ligation and cDNA
size-selection steps, all of which are known to increase
the potential for bias prior to sequencing [28,29]. This
number is probably an underestimate since we consid-
ered only reads that fall within non-exonic regions. Exo-
nic sequences that are part of transcripts that have no
known function were not counted due to the limitations
discussed earlier. Also, because the issues with reverse-
transcriptase mentioned above make it difficult to
unambiguously define the strand of all RNAs, antisense
exonic reads would be counted as exonic reads, also
decreasing the fraction of the true ‘dark matter’ RNAs.
The minimal sample preparation employed in this study
more closely reflects the native RNA population abun-
dance compared with amplification-based, next-genera-
tion platforms. We also find that total cellular RNA has
a much higher complexity than polyA+ RNA, which is
highly enriched for transcripts comprised of currently
annotated exonic sequences across a variety of cell types
and tissues. A methodological choice that assumes
RNAs need to be polyadenylated in order to be worthy
of study by discarding everything without a polyA tail is,
thus, certain to leave gaping holes in understanding of
the transcriptome. We further show that the intergenic
space in regions devoid of known, annotated transcripts
harbours very long stretches (for example, hundreds of
kb), of abundantly transcribed and likely non-protein
encoding RNA species, even though we cannot exclude
a possibility that some of transcripts in the vlinc regions
may encode proteins. Our understanding of the reper-
toire of these types of RNAs remains far from complete,
as we have identified hundreds of new loci by profiling
just seven samples from two types of tumours. Further-
more, the statistically significant overlap between the
intergenic vlinc RNAs found in tumours in this work
and the lincRNAs found in the normal human embryo-
nal and stem cells [27] raises the interesting hypothesis
that these RNAs in the vlinc regions function in specific
capacities early in development, only to be silenced in
differentiated cells and reactivated during malignant
transformation. These transcripts appear to be readily
identifiable in tumours, particularly poorly differentiated,
‘stem cell like’ tumours such as EFT, but less so in nor-
mal tissues, which suggests functional roles in both
development and oncogenesis. Such expressed RNA spe-
cies may also have potential usefulness as diagnostic
biomarkers for specific cancer types, as exemplified pre-
viously by the HOTAIR lincRNA [30] and other non-
coding RNAs [31] as well as in other diseases [32]. It
would be interesting to determine whether vlincs share
common functional properties with macro ncRNA iden-
tified as regulators of imprinting [33]. Further analysis
of more tumours from a variety of individuals will be
required in order to establish conclusive connections
between expressed regions and cancer aetiology.
Materials and methods
RNA
Total RNA was obtained from commercial sources for
t h eK 5 6 2c e l ll i n e( A m b i o n ,T e x a s ,U S A )a n dn o r m a l
liver and normal brain tissues (Clontech, CA, USA).
Total RNA was isolated from a pair of cell lines from a
patient with EFT, one established at diagnosis (CHLA-9)
and the second from a nodal metastasis obtained after
chemotherapy (CHLA-10) [34]. Most EFT tumours
express a fusion protein (EWSR1/FL1-1 or equivalent)
generated from a translocation and fusion between
EWSR1 and an ETS family gene. The fusion protein acts
as a transcription regulator and transcriptome sequen-
cing of this tumour is probably to reveal mis-expressed
RNAs involved in neoplastic transformation. Cell lines
tested mycoplasma-free. Cell line identity was validated
using patient bone marrow by the short tandem repeat
(STR) assay [35] and verified by STR at time of nucleic
acid extraction for these experiments. Cell lines can be
obtained from the Children’s Oncology Group reposi-
tory at http://www.COGcell.org. The EFT tissues were
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of Los Angeles, USA, and the detail of the specimens
could be obtained from Dr Timothy Triche [triche@usc.
edu]. Briefly, their properties were as follows:
1. Primary No.2 tumour: sacral tumour; age -13
years and 9 months; EWSR1 gene rearrangement
positive by FISH
2. Metastasis No.2 tumour: lung metastasis; same
patient as Primary No.2 tumour
3. Primary No.3 tumour: paraspinal tumour; age - 16
years and 9 months; EWSR1 gene rearrangement
positive by FISH
4. Metastasis No.4 tumour: metastasis of a primary
thoraco-abdominal tumour; age -14 years and 8
months; real-time polymerase chain reaction and
sequence analysis confirmed type I fusion of
EWSR1/FLI-1 genes.
Before further fractionation, total RNA was treated
with DNase I as follows: 50 μg of total RNA was mixed
with 10 μL of 10X DNase I buffer (Roche); 2 μL of RNa-
seOut (Invitrogen, CA, USA); and 8 μLo fr e c o m b i n a n t
DNase I (10 U/μL, Roche, CA, USA) and incubated for
45 min at 37°C. The RNA was then purified using the
RNeasy MinElute kit (Invitrogen).
The DNase I-treated total RNA was either unfractio-
nated (total RNA) or fractionated using one of the fol-
lowing methods: (1) depleted of ribosomal RNA (rRNA)
using the RiboMinus kit (Invitrogen); (2) polyA+ frac-
tion was selected using a magnetic bead-based purifica-
tion kit (Dynabeads mRNA purification kit, Invitrogen);
or, (3) polyA+ fraction was selected using the oligo-dT
cellulose method (Micro Poly(A)Purist Kit, Ambion,
Texas, USA).
Preparation of RNA for sequencing
Except where noted, 100-400 ng of DNase I -treated
RNA was mixed with the following reagents from the
SuperScript III kit (Invitrogen). First, 10 μLo f5 0n g / μL
Random Hexamers and 2 μLo f1 0m Md N T P sw e r e
added in the total volume of 25 μL. The mixture was
then placed in a thermocycler and heat denatured at 65°
C for 5 min followed by rapid cooling on ice. Next, 5
μL of 10X cDNA synthesis buffer, 5 μLo f0 . 1MD T T
and 10 μLo f2 5m MM g C l 2 were added. The samples
were returned to the thermocycler and allowed to incu-
bate at 15°C for 20 min. Then, 2.5 μLo fR N a s e O u ta n d
2.5 μL of SuperScript III reverse transcriptase were
added and the samples incubated at 25°C for 10 min,
42°C for 40 min, 55°C for 50 min and 70°C for 10 min.
After reverse transcription, RNA was removed by add-
ing 1 μLo fR N a s e H( I n v i t r o g e n )a n d1μLo fR N a s eI f
(New England BioLabs, MA, USA) to each sample and
incubating at 37°C for 30 min. The cDNA was then pur-
ified by two rounds of purification over Performa col-
umns (EdgeBio, MD, USA) and quantified using a
NanoDrop spectrophotometer.
Next, a 3’ poly-A tail was added to the cDNA samples.
cDNA (100 ng) was mixed with a control oligo to moni-
tor tail length and water in a total volume of 33.5 μL.
The mixture was denatured at 95°C for 5 min followed
by rapid cooling on ice. Five microlitres of 2.5 mM
CoCl2,5μL of 10x terminal deoxynucleotidyl transferase
(TdT) buffer (New England BioLabs), 5 μLo f5 0μM
dATP and 1.5 μL of TdT (20 U/μL, New England Bio-
Labs) was then added and the samples incubated at 42°
C for 1 h and at 70°C for 10 min.
The 3’ ends of the poly-A-tailed cDNA were then
blocked with biotin-ddATP. The sample was denatured
at 95°C for 5 min followed by rapid cooling on ice. We
then added 0.3 μL of 1 mM biotin-ddATP (Perkin
Elmer, CA, USA) and 1.5 μL of TdT followed by incu-
bation at 37°C for 45 min and 70°C for 10 min.
The control oligo was removed by digestion with the
USER enzyme (New England BioLabs). Then 1 μLo f
the USER enzyme (1 U) was added to the sample and
incubated at 37°C for 30 min.
The sample was then purified using AMPure beads
(Agencourt, MA, USA) by bringing the volume up to
60 μL with water and adding 72 μLo ft h eA M P u r e
beads followed by incubation at room temperature for
30 min with agitation. The beads were then captured on
a magnetic stand and washed twice with 70% ethanol.
The beads were allowed to air dry for 5-7 min, resus-
pended in 20 μL of water and left open for 30 min on
the magnet. The eluate was collected and the beads
were resuspended again in 20 μL of water and then left
for 5 min on the magnet. The eluate was collected again
and combined with the first eluate.
Typically, samples were hybridized to the HeliScope
flow cell in 20 μL at a loading concentration of
100-350 pM.
SMS reads to the genome
SMS reads were trimmed for leading T homopolymers
and were filtered for reads with a minimal length of 25
bases after trimming using a suite of Helicos tools avail-
able at http://open.helicosbio.com/mwiki/index.php/
Releases and described at http://open.helicosbio.com/
helisphere_user_guide/index.html. Alignments were con-
ducted with indexDPgenomic software freely available
on the Helicos website http://open.helicosbio.com/
mwiki/index.php/Releases. The aligner maximizes the
aligned yield of SMS reads due to the ability to align
reads in which the predominant error is represented by
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the genomic alignments, reads were aligned to the
NCBIv36 version of the genome supplemented with the
complete ribosomal repeat unit (Gen Bank Accession
U13369.1) or the DM3 version of the fly genome sup-
plemented with the complete ribosomal repeat unit
(Gen Bank Accession M21017.1) using the Helicos
BASIC analysis pipeline http://open.helicosbio.com/heli-
sphere_user_guide/index.html. The sequence reads were
filtered to include reads with a minimal length of 25
bases and aligned using a stringent normalized score of
4.5 (human genome) and 4.3 (fly genome). Aligned
reads were further filtered for reads having a unique
best alignment score. The mapped reads were then
compared to UCSC genes and FlyBase gene annotations
to partition them into exonic, intronic and intergenic
reads.
The normalized score was defined as follows:
Score = (No. matches*5 - No. mismatches*4)/
length_read
For example, in the following alignment:
Tag Sequence CCTCCGTGTTGTTCCAGCC-CAG
TGCTCGCAGG
Ref Sequence C-TCCGTGTTGTTCCAGCCACAGT
GCTCGCAGG
Length of alignment block: 33
Length of tag sequence: 32
Number of matches: 31
Number of errors: 2
Score: (31*5) - (2*4) = 155 - 8 = 147
Normalized score = 147/32 = 4.59375
Identification of the vlinc RNA domains
Reads not overlapping the genic regions from the Ewing
tumours and K562 were pooled and used to generate
the densities of read coverage throughout the genome.
The vlinc domains were defined in the Integrated Gen-
ome Browser http://www.bioviz.org/igb/download.shtml
by applying the following thresholds to the density
graphs for each chromosome:
Threshold = 80th percentile
MaxGap = 5000
MinRun = 50000
Comparison with the FANTOM 3 dataset
The coordinates of the 181,047 reliable 5’/3’ clusters
described in the Table 3 of the FANTOM3 consortium
paper [5] were downloaded from the FANTOM3 web-
site at ftp://fantom.gsc.riken.jp/FANTOM3/boundary_-
set/pair53_clusters.txt.gz. The coordinates were lifted
from the mm5 version of the mouse genome to hg18
in a two step process using the UCSC liftOver tool:
mm5- > mm8 and mm8- > hg18.
Additional material
Additional File 1: Definition of the ‘dark matter’ RNA. Provides a
definition of what kind of RNA molecules should be included in the ‘dark
matter’ RNA realm and argumentation for their inclusion.
Additional File 2: Table S1. Distribution of single-molecule sequencing
reads obtained from polyA+, rRNA-depleted (Ribominus) and total RNA
from different tissues among different types of annotations.
Additional File 3: Table S2. Distribution of single-molecule sequencing
reads obtained from ribosomal RNA-depleted (Ribominus) RNA from
Ewing Family of Tumours solid tumours and cell lines.
Additional File 4: Table S3. Coordinates of the very long intergenic
regions and their normalized expression levels in each tissue.
Additional File 5: Table S4. Normalized expression levels of University
of California Santa Cruz genes in each tissue. The total number of reads
within each of the regions was normalized to 10 M non-ribosomal non-
mitochondrial unique reads in each sample.
Additional File 6: Table S5. Spearman correlation matrix based on
expression of very long intergenic non-codings and University of
California Santa Cruz genes between different tumour and normal tissues
Additional File 7: Table S6. Overlap between very long intergenic non-
codings and FANTOM3 intergenic clusters of over 50 kb.
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